Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
5S ribosomal RNA pseudogene 477 (RNA5SP477) is a nonfunctional DNA sequence homologous to the 5S ribosomal RNA gene. Pseudogenes such as this result from gene duplication or retrotransposition events and have lost their ability to code for a functional RNA due to accumulated mutations[4]. Unlike the canonical 5S rRNA, which is an essential structural RNA within the ribosome, 5S rRNA pseudogenes are typically not transcribed or translated, and do not play active roles in cellular processes[4]. There are no known therapeutic applications, disease associations, or drug interactions for RNA5SP477. Its existence is primarily of genomic and evolutionary interest and does not constitute a druggable or therapeutic target[4][2].
Not applicable; as a pseudogene, there is no drug mechanism of action attributed to this locus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 5S ribosomal RNA pseudogene 477 (RNA5SP477).